Jun 5 |
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
|
Jun 5 |
Psychedelic stocks fall as FDA panel rejects MDMA therapy
|
Jun 4 |
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (updated)
|
May 31 |
Psychedelic stocks mixed as FDA comments on MDMA therapy (update)
|
May 23 |
Psychedelics Closer To Commercialization; Compass Far And Away The Leader
|
May 21 |
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
|
May 13 |
COMPASS Pathways plc (NASDAQ:CMPS) Q1 2024 Earnings Call Transcript
|
May 11 |
COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript
|
May 9 |
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
|
May 8 |
COMPASS Pathways ADS GAAP EPS of -$0.55 misses by $0.07
|